Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 3Phase 1/2 3Phase 1 2Phase 2/3 1

Status

Recruiting 3

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3NET 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 80Breast Neoplasms 52Prostatic Neoplasms 42Lung Neoplasms 29Multiple Myeloma 28Parkinson Disease 4, Autosomal Dominant Lewy Body 22Neoplasms 21Neoplasm Metastasis 20Leukemia, Lymphocytic, Chronic, B-Cell 19Colorectal Neoplasms 19Carcinoma, Renal Cell 19Ovarian Neoplasms 17Squamous Cell Carcinoma of Head and Neck 13Recurrence 12Leukemia, Myeloid, Acute 12Urinary Bladder Neoplasms 11Small Cell Lung Carcinoma 11Pancreatic Neoplasms 11Myasthenia Gravis 11Endometrial Neoplasms 11Triple Negative Breast Neoplasms 10Stomach Neoplasms 9Non-Muscle Invasive Bladder Neoplasms 9Nasopharyngeal Carcinoma 9Lymphoma, Large B-Cell, Diffuse 9Fallopian Tube Neoplasms 9Lymphoma, Non-Hodgkin 8Lymphoma, Follicular 8Carcinoma 8Burkitt Lymphoma 8

Interventions

pembrolizumab 1X-Rays 1Surgical Procedures, Operative 1Specimen Handling 1Neoadjuvant Therapy 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Liposarcoma × 30 days × Clear all
NCT06422806 2026-05-26

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

National Cancer Institute (NCI)

Phase 3 Recruiting
365 enrolled
Sarcoma

Liposarcoma, Histiocytoma, Malignant Fibrous

NCT04031677 2026-05-22

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting
250 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma

NCT06881992 2026-05-18

Tumor HI

Rezolute

Phase 3 Recruiting
16 enrolled
EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡